TVTX
TRAVERE THERAPET (TVTX)
NASDAQ
$56.92+$0.07 (+0.12%)
Price as of Oct 02, 2026 5:38 PM EDT
  • $5.4B
    Market Cap
  • 134.72%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
JANUS HENDERSON GROUP PLC
12.28%
11.4M
+908,420 (+7.95%)
Mar 31, 2026
JUPITER TOPCO LLC
12.18%
11.3M
+11.3M (+100.00%)
Jun 30, 2026
N/A
12.18%
11.3M
+11.3M (+100.00%)
Jun 30, 2026
BLACKROCK, INC.
8.63%
8.0M
+228,630 (+2.85%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
8.62%
8.0M
+460,839 (+5.75%)
Dec 31, 2024
BLACKROCK INC.
8.22%
7.6M
-151,977 (-1.99%)
Jun 30, 2024
FMR LLC
7.63%
7.1M
-3.9M (-54.55%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions1.7B (75.35%)
  • Mutual Funds495.3M (22.25%)
  • Insiders53.5M (2.40%)
  • Other0 (0.00%)

Insider Transactions

  • 2.40% (53.5M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 11
    Number of InsiderSelling (last 12 months)
  • $573.2M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 17, 2026
$0.00
8,282
$0.00
44,837
Dube Eric M
CHIEF EXECUTIVE OFFICER
Exempt
Sep 17, 2026
$0.00
108,493
$0.00
0
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 17, 2026
$185,516.80
8,282
$22.40
125,348
Dube Eric M
CHIEF EXECUTIVE OFFICER
Exempt
Sep 17, 2026
$2.5M
108,493
$23.34
541,379
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sell
Sep 17, 2026
$538,917.19
8,282
$65.07
117,066
Dube Eric M
CHIEF EXECUTIVE OFFICER
Sell
Sep 17, 2026
$6.6M
101,691
$64.59
439,688
Dube Eric M
CHIEF EXECUTIVE OFFICER
Sell
Sep 17, 2026
$441,795.34
6,802
$64.95
432,886
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$0.00
350
$0.00
0
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$1.1M
100,000
$11.25
217,066
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$0.00
55,000
$0.00
0
Dube Eric M
CHIEF EXECUTIVE OFFICER
Exempt
Sep 16, 2026
$4.6M
195,841
$23.34
628,727
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$0.00
57,500
$0.00
0
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$850,300.00
55,000
$15.46
272,066
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$6,286.00
350
$17.96
98,547
Dube Eric M
CHIEF EXECUTIVE OFFICER
Sell
Sep 16, 2026
$6.3M
99,716
$63.26
529,011
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$850,300.00
55,000
$15.46
153,547
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$476,232.96
17,717
$26.88
289,783
ROTE WILLIAM E.
Chief Research Officer
Exempt
Sep 16, 2026
$1.5M
57,500
$26.88
211,047
Dube Eric M
CHIEF EXECUTIVE OFFICER
Sell
Sep 16, 2026
$6.1M
96,125
$63.64
432,886
ROTE WILLIAM E.
Chief Research Officer
Sell
Sep 16, 2026
$4.1M
65,104
$63.12
145,943
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sell
Sep 16, 2026
$5.9M
93,604
$63.25
196,179
ROTE WILLIAM E.
Chief Research Officer
Sell
Sep 16, 2026
$3.0M
47,746
$63.61
98,197
Dube Eric M
CHIEF EXECUTIVE OFFICER
Exempt
Sep 16, 2026
$0.00
195,841
$0.00
108,493
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sell
Sep 16, 2026
$5.0M
79,113
$63.65
117,066
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$0.00
100,000
$0.00
0
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$0.00
55,000
$0.00
0
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Exempt
Sep 16, 2026
$0.00
17,717
$0.00
500
Inrig Jula
EVP, Head of R&D & CMO
Exempt
Sep 15, 2026
$0.00
32,395
$0.00
43,605
Dube Eric M
CHIEF EXECUTIVE OFFICER
Exempt
Sep 15, 2026
$2.2M
95,666
$23.34
528,552
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Exempt
Sep 15, 2026
$0.00
2,500
$0.00
0